These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32539916)

  • 21. A novel, rapid and sensitive UPLC-MS/MS method for the determination of macitentan in patients with pulmonary arterial hypertension.
    Albayrak M; Atıla A; Yılmazel Ucar E; Araz O; Kadıoglu Y
    Biomed Chromatogr; 2019 May; 33(5):e4502. PubMed ID: 30725476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending-dose study.
    Small D; Ferguson-Sells L; Dahdah N; Bonnet D; Landry J; Li B
    Br J Clin Pharmacol; 2019 Oct; 85(10):2302-2309. PubMed ID: 31222765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis.
    Li Q; Kuang HY; Wu YH; Lu TW; Yi QJ
    Medicine (Baltimore); 2019 May; 98(20):e15632. PubMed ID: 31096477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An LC-MS/MS method for the determination of five erectile dysfunction drugs and their selected metabolites in hair.
    Lee S; Choi B; Kim J; In S; Baeck S; Oh SM; Chung KH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():1-10. PubMed ID: 25531864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study.
    Cadenas-Menéndez S; Álvarez Vega P; Oterino Manzanas A; Alonso Lecue P; Roig Figueroa V; Bedate Díaz P; Ortiz de Saracho J; Cifrián Martínez JM
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):481-487. PubMed ID: 31879844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification.
    Simiele M; Pensi D; Pasero D; Ivaldi F; Rinaldi M; Di Perri G; Ranieri VM; D'Avolio A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():35-40. PubMed ID: 26253809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.
    Vachiéry JL; Galiè N; Barberá JA; Frost AE; Ghofrani HA; Hoeper MM; McLaughlin VV; Peacock AJ; Simonneau G; Blair C; Miller KL; Langley J; Rubin LJ;
    J Heart Lung Transplant; 2019 Feb; 38(2):194-202. PubMed ID: 30522722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: A systematic review and meta-analysis.
    Lei Y; Zhang X; Lin H; Feng Y; Wang J; Luo R
    Mod Rheumatol; 2021 Jan; 31(1):151-161. PubMed ID: 31829087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry.
    Garcia-Martínez S; Rico E; Casal E; Grisaleña A; Alcaraz E; King N; Leal N; Navarro I; Campanero MÁ
    J Pharm Biomed Anal; 2018 Feb; 150():427-435. PubMed ID: 29289894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional estimation of endothelin-1 receptor antagonism by bosentan, macitentan and ambrisentan in human pulmonary and radial arteries in vitro.
    Angus JA; Soeding PF; Hughes RJA; Wright CE
    Eur J Pharmacol; 2017 Jun; 804():111-116. PubMed ID: 28300593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination Therapy of Pulmonary Arterial Hypertension with Vardenafil and Macitentan Assessed in a Human Ex Vivo Model.
    Hoenicka M; Golovchenko S; Englert L; Spaeth M; Shoshiashvili L; Großer C; Hofmann HS; Ried M
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):287-295. PubMed ID: 30826900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study.
    Omura J; Makanji Y; Tanabe N; Yu DY; Tan JY; Lim S; Kouhkamari MH; Casorso J; Wu DB; Bloomfield P
    Pulm Ther; 2023 Dec; 9(4):511-526. PubMed ID: 37991630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension.
    Wu S; Hoang HB; Yang JZ; Papamatheakis DG; Poch DS; Alotaibi M; Lombardi S; Rodriguez C; Kim NH; Fernandes TM
    Chest; 2022 Dec; 162(6):1360-1372. PubMed ID: 35841932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive Predictors for Response to Ambrisentan Combination Therapy in Pulmonary Arterial Hypertension.
    Hatano M; Abe K; Koike G; Takahashi T; Tunmer G; Kiely DG
    Int Heart J; 2022; 63(1):99-105. PubMed ID: 35095084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validated UPLC-MS/MS assay for the determination of synthetic phosphodiesterase type-5 inhibitors in postmortem blood samples.
    Proença P; Mustra C; Marcos M; Franco JM; Corte-Real F; Vieira DN
    J Forensic Leg Med; 2013 Aug; 20(6):655-8. PubMed ID: 23910856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
    Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
    Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag:  a case report.
    Lattanzio M; Ferrari M; Martini S; Ceriani F; Imporzani A; Marino F; De Ponti R; Cosentino M
    J Med Case Rep; 2022 Oct; 16(1):385. PubMed ID: 36258237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
    Fox B; Langleben D; Hirsch AM; Schlesinger RD; Eisenberg MJ; Joyal D; Blenkhorn F; Lesenko L
    Can J Cardiol; 2013 Jun; 29(6):672-7. PubMed ID: 22819360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension.
    Buendia JA; Patino DG; Lindarte EF
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(8):967-973. PubMed ID: 37403496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.